2 weeks Sarepta Therapeutics (SRPT) Lags Q4 Earnings Estimates Zacks

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -19.79% and 2.83%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?